Insights from ORION studies: focus on inclisiran safety

被引：8
|
作者：
Catapano, Alberico Luigi [1 ,2 ]
Pirillo, Angela [2 ,3 ]
Norata, Giuseppe Danilo [1 ,3 ]
机构：
[1] Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, I-20133 Milan, Italy
[2] IRCCS MultiMed, Via Milanese 300, I-20099 Milan, Italy
[3] E Bassini Hosp, Ctr Study Atherosclerosis, Via M Gorki 50, I-20092 Milan, Italy
来源：
CARDIOVASCULAR RESEARCH | 2021年 / 117卷 / 01期
关键词：
ANTISENSE OLIGONUCLEOTIDES; RISK;
D O I：
10.1093/cvr/cvaa139
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：24 / 26
页数：3
相关论文
共 50 条
  • [41] EFFICACY, SAFETY AND PHARMACOKINETICS OF INCLISIRAN BY RENAL FUNCTION
    Kallend, D.
    Collins, M.
    Kastelein, J.
    Landmesser, U.
    Leiter, L.
    Ray, K.
    Robson, R.
    Stoekenbroek, R.
    Wright, R. S.
    Wijngaard, P.
    ATHEROSCLEROSIS, 2019, 287 : E38 - E38
  • [42] New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
    Ruscica, Massimiliano
    Sirtori, Cesare Riccardo
    Ferri, Nicola
    Corsini, Alberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0E) : E59 - E62
  • [43] Where to focus? Insights from safety personnel and external safety consultants on lessons learned about safety climate interventions-A qualitative approach
    Lee, Jin
    Huang, Yueng-Hsiang
    Dainoff, Marvin J.
    He, Yimin
    JOURNAL OF SAFETY RESEARCH, 2021, 79 : 51 - 67
  • [44] Development of Novel siRNA Therapeutics: A Review with a Focus on Inclisiran for the Treatment of Hypercholesterolemia
    Ebenezer, Oluwakemi
    Comoglio, Pietro
    Wong, Gane Ka-Shu
    Tuszynski, Jack A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [45] Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials
    Landmesser, Ulf
    Koenig, Wolfgang
    Leiter, Lawrence A.
    Raal, Frederick J.
    Ray, Kausik K.
    Wright, R. Scott
    Han, Jackie
    Conde, Lorena Garcia
    Schwartz, Gregory G.
    ATHEROSCLEROSIS, 2023, 386
  • [46] EFFECT OF INCLISIRAN ON LDL-C REDUCTION ACROSS DIFFERENT BACKGROUND LIPID LOWERING TREATMENTS: ANALYSES FROM ORION-11
    Ray, Kausik Kumar
    Kallend, David
    Leiter, Lawrence
    Raal, Frederick
    Koenig, Wolfgang
    Wright, Scott
    Wijngaard, Peter
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2078 - 2078
  • [47] Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies
    Cicero, Arrigo F. G.
    Fogacci, Federica
    Zambon, Alberto
    Toth, Peter P.
    Borghi, Claudio
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 13
  • [48] PIPELINERS FOCUS ON AUTOMATED CLASS LOCATION STUDIES FOR SAFETY
    WHITE, RM
    HUGHES, RH
    PIPELINE & GAS JOURNAL, 1994, 221 (09) : 81 - 83
  • [49] Pipeliners focus on automated class location studies for safety
    White, R.Michael
    Hughes, R.Harvey
    Pipeline and Gas Journal, 1994, 221 (09): : 81 - 83
  • [50] Effectiveness and safety of Inclisiran in hyperlipidemia treatment: An overview of systematic reviews
    Li, Jiayi
    Lei, Xiangguo
    Li, Zihao
    Yang, Xi
    MEDICINE, 2023, 102 (03) : E32728
12345